Gyeongbo Pharmaceutical has newly appeared among the top searched stocks.


As of 10:30 AM on the 3rd, Gyeongbo Pharmaceutical is trading at 15,500 KRW, down 0.96% from the previous day. This represents a 56.41% increase compared to November 10. Gyeongbo Pharmaceutical is known as a manufacturer and seller of pharmaceutical raw materials.

Over the past five days, individual investors have net purchased 86,702 shares, while foreigners and institutions have net sold 36,225 shares and 33,787 shares, respectively.


On December 2, Gyeongbo Pharmaceutical was a market topic with the news of developing the COVID-19 treatment Nafamostat, showing a strong performance.



※Source: AI Investment Assistant AI Rasero


※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing